Arkhammar P - Search Results

1

Safety update on the use of recombinant activated factor VII in approved indications.

Neufeld EJ, Négrier C, Arkhammar P, Benchikh el Fegoun S, Simonsen MD, Rosholm A, Seremetis S. Neufeld EJ, et al. Among authors: arkhammar p. Blood Rev. 2015 Jun;29 Suppl 1:S34-41. doi: 10.1016/S0268-960X(15)30006-0. Blood Rev. 2015. PMID: 26073367 Review.

2

The use of recombinant activated factor VII in patients with acquired haemophilia.

Tiede A, Amano K, Ma A, Arkhammar P, El Fegoun SB, Rosholm A, Seremetis S, Baudo F. Tiede A, et al. Among authors: arkhammar p. Blood Rev. 2015 Jun;29 Suppl 1:S19-25. doi: 10.1016/S0268-960X(15)30004-7. Blood Rev. 2015. PMID: 26073365 Review.

3

Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors.

Santagostino E, Escobar M, Ozelo M, Solimeno L, Arkhammar P, Lee HY, Rosu G, Giangrande P. Santagostino E, et al. Among authors: arkhammar p. Blood Rev. 2015 Jun;29 Suppl 1:S9-18. doi: 10.1016/S0268-960X(15)30003-5. Blood Rev. 2015. PMID: 26073369 Review.

4

40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors.

Ljung R, Karim FA, Saxena K, Suzuki T, Arkhammar P, Rosholm A, Giangrande P; Pioneer™1 Investigators. Ljung R, et al. Among authors: arkhammar p. J Thromb Haemost. 2013 Jul;11(7):1260-8. doi: 10.1111/jth.12237. J Thromb Haemost. 2013. PMID: 23578227 Free article. Clinical Trial.

5

The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial.

Lentz SR, Rangarajan S, Karim FA, Andersen PD, Arkhammar P, Rosu G, Mahlangu J. Lentz SR, et al. Among authors: arkhammar p. Blood Coagul Fibrinolysis. 2017 Apr;28(3):224-229. doi: 10.1097/MBC.0000000000000584. Blood Coagul Fibrinolysis. 2017. PMID: 27427786 Free PMC article. Clinical Trial.

6

Establishment and application of in vitro membrane potential assays in cell lines with endogenous or recombinant expression of ATP-sensitive potassium channels (Kir6.2/SUR1) using a fluorescent probe kit.

Arkhammar P, Wahl P, Gerlach B, Fremming T, Hansen JB. Arkhammar P, et al. J Biomol Screen. 2004 Aug;9(5):382-90. doi: 10.1177/1087057104263911. J Biomol Screen. 2004. PMID: 15296637

7

Functional identification and monitoring of individual alpha and beta cells in cultured mouse islets of Langerhans.

Hjortoe GM, Hagel GM, Terry BR, Thastrup O, Arkhammar PO. Hjortoe GM, et al. Among authors: arkhammar po. Acta Diabetol. 2004 Dec;41(4):185-93. doi: 10.1007/s00592-004-0164-9. Acta Diabetol. 2004. PMID: 15660202

8

New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells.

Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB. Nielsen FE, et al. Among authors: arkhammar po. J Med Chem. 2006 Jul 13;49(14):4127-39. doi: 10.1021/jm060042j. J Med Chem. 2006. PMID: 16821773

9

Synthesis and pharmacological evaluation of 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyanomethylsulfonylphenyl)acylamide derivatives as potential activators of ATP sensitive potassium channels.

Schou SC, Hansen HC, Tagmose TM, Boonen HC, Worsaae A, Drabowski M, Wahl P, Arkhammar PO, Bodvarsdottir T, Antoine MH, Lebrun P, Hansen JB. Schou SC, et al. Among authors: arkhammar po. Bioorg Med Chem. 2005 Jan 3;13(1):141-55. doi: 10.1016/j.bmc.2004.09.051. Bioorg Med Chem. 2005. PMID: 15582459

10

Arylcyanoguanidines as activators of Kir6.2/SUR1K ATP channels and inhibitors of insulin release.

Tagmose TM, Schou SC, Mogensen JP, Nielsen FE, Arkhammar PO, Wahl P, Hansen BS, Worsaae A, Boonen HC, Antoine MH, Lebrun P, Hansen JB. Tagmose TM, et al. Among authors: arkhammar po. J Med Chem. 2004 Jun 3;47(12):3202-11. doi: 10.1021/jm031018y. J Med Chem. 2004. PMID: 15163199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters